Breeze Meds vs Gala: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Breeze Meds beats Gala overall, scoring 7.3/10 vs 7.2/10. Gala is more affordable at $149/mo vs $199/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa.
A side-by-side comparison of Breeze Meds and Gala covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#34 of 49Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsGala
#40 of 49Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.
Visit Gala| Feature | Breeze Meds | Gala |
|---|---|---|
| Our Score | 7.3/10 | 7.2/10 |
| Starting Price | $199/mo | $149/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging |
| Ranking | #34 | #40 |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required — order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Very limited independent reviews and unclear company structure — legitimacy is hard to verify
- −Oral options at $299-399/mo are significantly more expensive than injectable alternatives
- −Not available in all 50 states — varies by provider licensure in your state
Gala
Pros
- +Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
- +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
- −Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
- −Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
- −Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Our Verdict
Breeze Meds edges out Gala with a score of 7.3/10 vs 7.2/10. If budget is your priority, Gala starts at $149/mo compared to Breeze Meds's $199/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging.
Still undecided? Editor's #1 Overall Pick
Embody
$299/mo · 7.3/10 · Compounded
If neither Breeze Meds nor Gala feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Breeze Meds or Gala tend to look at next.
- Breeze Meds vs MyStart Health$299/mo
- Breeze Meds vs Direct Meds GLP-1$297/mo
- Breeze Meds vs DudeMeds$149/mo
- Gala vs TMates$158/mo
- Gala vs FeelGood$149/mo
- Gala vs Oak Longevity$130/mo